JENNIFER PHILLIPS: Open Payments
NPI 1700301272 · O FALLON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,614 in 77 payments from 16 companies in 2025. Trend: 2023 $3,364 · 2024 $3,697 · 2025 $1,614
Food & beverage: $1,537Education: $77
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $373 |
| Janssen Biotech, Inc. | 10 | $266 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $251 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $157 |
| Gilead Sciences, Inc. | 4 | $94 |
| Madrigal Pharmaceuticals | 3 | $71 |
| PFIZER INC. | 4 | $70 |
| Lilly USA, LLC | 3 | $67 |
| Intercept Pharmaceuticals, Inc. | 3 | $64 |
| QOL Medical, LLC | 2 | $43 |
Products named: TREMFYA, RINVOQ, ENTYVIO, XIFAXAN, LINZESS, REZDIFFRA, XELJANZ, OMVOH.
Industry payments across MO — which companies pay providers there.
